These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 24270010)

  • 1. Stable RNA nanoparticles as potential new generation drugs for cancer therapy.
    Shu Y; Pi F; Sharma A; Rajabi M; Haque F; Shu D; Leggas M; Evers BM; Guo P
    Adv Drug Deliv Rev; 2014 Feb; 66():74-89. PubMed ID: 24270010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.
    Shu Y; Haque F; Shu D; Li W; Zhu Z; Kotb M; Lyubchenko Y; Guo P
    RNA; 2013 Jun; 19(6):767-77. PubMed ID: 23604636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.
    Xu C; Haque F; Jasinski DL; Binzel DW; Shu D; Guo P
    Cancer Lett; 2018 Feb; 414():57-70. PubMed ID: 28987384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Planar Phi29 pRNA Three-Way Junction to Control Size and Shape of RNA Nanoparticles for Biodistribution Profiling in Mice.
    Haque F; Xu C; Jasinski DL; Li H; Guo P
    Methods Mol Biol; 2017; 1632():359-380. PubMed ID: 28730451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells.
    Shu Y; Cinier M; Shu D; Guo P
    Methods; 2011 Jun; 54(2):204-14. PubMed ID: 21320601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional assays for specific targeting and delivery of RNA nanoparticles to brain tumor.
    Lee TJ; Haque F; Vieweger M; Yoo JY; Kaur B; Guo P; Croce CM
    Methods Mol Biol; 2015; 1297():137-52. PubMed ID: 25896001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.
    Shu D; Li H; Shu Y; Xiong G; Carson WE; Haque F; Xu R; Guo P
    ACS Nano; 2015 Oct; 9(10):9731-40. PubMed ID: 26387848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, conjugation, and labeling of multifunctional pRNA nanoparticles for specific delivery of siRNA, drugs, and other therapeutics to target cells.
    Guo P; Shu Y; Binzel D; Cinier M
    Methods Mol Biol; 2012; 928():197-219. PubMed ID: 22956144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells.
    Shu Y; Shu D; Haque F; Guo P
    Nat Protoc; 2013 Sep; 8(9):1635-59. PubMed ID: 23928498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA.
    Cui D; Zhang C; Liu B; Shu Y; Du T; Shu D; Wang K; Dai F; Liu Y; Li C; Pan F; Yang Y; Ni J; Li H; Brand-Saberi B; Guo P
    Sci Rep; 2015 Jul; 5():10726. PubMed ID: 26137913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dynamic, motile and deformative properties of RNA nanoparticles facilitate the third milestone of drug development.
    Li X; Bhullar AS; Binzel DW; Guo P
    Adv Drug Deliv Rev; 2022 Jul; 186():114316. PubMed ID: 35526663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design for controlled release of Dicer-substrate siRNA harbored in phi29 pRNA-based nanoparticles.
    Binzel DW; Guo S; Yin H; Lee TJ; Liu S; Shu D; Guo P
    Mol Ther Nucleic Acids; 2021 Sep; 25():524-535. PubMed ID: 34589275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using RNA nanoparticles with thermostable motifs and fluorogenic modules for real-time detection of RNA folding and turnover in prokaryotic and eukaryotic cells.
    Zhang H; Pi F; Shu D; Vieweger M; Guo P
    Methods Mol Biol; 2015; 1297():95-111. PubMed ID: 25895998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-Pot Production of RNA Nanoparticles via Automated Processing and Self-Assembly.
    Jasinski DL; Binzel DW; Guo P
    ACS Nano; 2019 Apr; 13(4):4603-4612. PubMed ID: 30888787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuning the size, shape and structure of RNA nanoparticles for favorable cancer targeting and immunostimulation.
    Guo S; Xu C; Yin H; Hill J; Pi F; Guo P
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jan; 12(1):e1582. PubMed ID: 31456362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Size and Shape of RNA Nanoparticles on Biodistribution.
    Jasinski DL; Li H; Guo P
    Mol Ther; 2018 Mar; 26(3):784-792. PubMed ID: 29402549
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Jin K; Liao YC; Cheng TC; Li X; Lee WJ; Pi F; Jasinski D; Chen LC; Phelps MA; Ho YS; Guo P
    Mol Pharm; 2024 Feb; 21(2):718-728. PubMed ID: 38214504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current advances in Phi29 pRNA biology and its application in drug delivery.
    Ye X; Hemida M; Zhang HM; Hanson P; Ye Q; Yang D
    Wiley Interdiscip Rev RNA; 2012; 3(4):469-81. PubMed ID: 22362726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA Micelles for the Systemic Delivery of Anti-miRNA for Cancer Targeting and Inhibition without Ligand.
    Yin H; Wang H; Li Z; Shu D; Guo P
    ACS Nano; 2019 Jan; 13(1):706-717. PubMed ID: 30543397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.